학술논문
Improvement of daily allergy control by sublingual immunotherapy: A MASK‐air® study.
Document Type
Article
Author
Bousquet, Jean; Sousa‐Pinto, Bernardo; Shamji, Mohamed H.; Anto, Josep M.; Klimek, Ludger; Canonica, G. Walter; Czarlewski, Wienczyslawa; Devillier, Philippe; Haahtela, Tari; Laune, Daniel; Mullol, Joaquim; Brussino, Luisa; Cecchi, Lorenzo; Kvedariene, Violeta; Morais‐Almeida, Mario; Mösges, Ralph; Niedoszytko, Marek; Papadopoulos, Nikolaos G.; Patella, Vincenzo; Pham‐Thi, Nhân
Source
Subject
*SUBLINGUAL immunotherapy
*CORPORATE directors
*
Language
ISSN
0954-7894
Abstract
MJ reports personal fees from ALK-Abello, personal fees from Allergopharma, personal fees from Stallergenes, personal fees from Anergis, personal fees from Allergy Therapeutics, personal fees from Leti, personal fees from HAL, during the conduct of the study; personal fees from GSK, personal fees from Novartis, personal fees from Teva, personal fees from Takeda, personal fees from Chiesi, outside the submitted work. JS reports grants and personal fees from SANOFI, personal fees from GSK, personal fees from NOVARTIS, personal fees from ASTRA ZENECA, personal fees from MUNDIPHARMA, personal fees from FAES FARMA, outside the submitted work. LC reports personal fees from Thermofisher, personal fees from Sanofi, personal fees from Astra Zeneca, personal fees from Novartis, outside the submitted work. PK reports personal fees from Adamed, personal fees from Berlin Chemie Menarini, personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, personal fees from Celon Pharma, personal fees from Polpharma, personal fees from Teva, personal fees from Novartis, personal fees from Glenmark, personal fees from Zentiva, outside the submitted work. [Extracted from the article]